Home / Companies / Carisma Therapeutics Inc. / 13 Jun 2024
Carisma Therapeutics Inc.: meeting of 13 Jun 2024
Votes reported on Form N-PX, item by item
126 Form N-PX filers reported votes at the Carisma Therapeutics Inc. meeting of 13 Jun 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 86.7% of reported votes for; 15 filers withheld from or voted against at least one nominee.
150 vote records from 48 filers. 2 of the 48 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
168 vote records from 127 filers. 17 of the 123 filers that marked the item either way voted against management. 4 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
75 vote records from 48 filers. 1 of the 48 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | For | Against * | For |
| State Street and SPDR | Split or no vote | For | For |
| American Century | For | Against * | For |
| Invesco | For | Against * | For |
| Equitable | For | For | For |
| Charles Schwab | For | For | For |
| Nuveen and TIAA | For | For | For |
| ProShares and ProFunds | For | For | For |
| John Hancock and Manulife | Split or no vote | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | Against * | For |
| J.P. Morgan | No report | For | No report |
| Goldman Sachs | No report | For | No report |
| PGIM and Prudential | No report | For | No report |
| Northern Trust and FlexShares | Split or no vote | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | Split or no vote | For | For |
| Voya | For | For | For |
| Nationwide | Split or no vote | For | For |
| Guggenheim and Rydex | For | For | For |
| BNY Mellon | No report | For | No report |
| Principal | Split or no vote | For | For |
| Pacific Life funds | For | For | For |
| Global X | For | For | For |
| Federated Hermes | No report | For | No report |
| AllianceBernstein | No report | For | No report |
| DWS | For | For | For |
| Baird | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Carisma Therapeutics Inc. meeting?
126 Form N-PX filers reported votes at the meeting of 13 Jun 2024. On say-on-pay, 17 of 123 voted against management (13.8%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Carisma Therapeutics Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Carisma Therapeutics Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Carisma Therapeutics Inc. with a meeting date within three days of 13 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.